AAAAAA

   
Results: 1-9 |
Results: 9
Gemcitabine in combination with new platinum compounds: An update
Authors: Gandara, DR Edelman, MJ Lara, PN Lau, DHM
Citation: Dr. Gandara et al., Gemcitabine in combination with new platinum compounds: An update, ONCOLOGY-NY, 15(3), 2001, pp. 13-17
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
Authors: Edelman, MJ Quam, H Mullins, B
Citation: Mj. Edelman et al., Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines, CANC CHEMOT, 48(2), 2001, pp. 141-144
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel
Authors: Edelman, MJ Gandara, DR Lau, DHM Lara, P Lauder, IJ Tracy, D
Citation: Mj. Edelman et al., Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel, CANCER, 92(1), 2001, pp. 146-152
Phase I study of docetaxel and topotecan in patients with solid tumors
Authors: Tkaczuk, KH Zamboni, WC Tait, NS Meisenberg, BR Doyle, LA Edelman, MJ Hausner, PF Egorin, MJ Van Echo, DA
Citation: Kh. Tkaczuk et al., Phase I study of docetaxel and topotecan in patients with solid tumors, CANC CHEMOT, 46(6), 2000, pp. 442-448
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation
Authors: Edelman, MJ Meyers, FJ Miller, TR Williams, SG Gandour-Edwards, R White, RWD
Citation: Mj. Edelman et al., Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation, UROLOGY, 55(4), 2000, pp. 521-525
RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma
Authors: Mack, PC Gandara, DR Bowen, C Edelman, MJ Paglieroni, T Schnier, JB Gelmann, EP Gumerlock, PH
Citation: Pc. Mack et al., RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma, CLIN CANC R, 5(9), 1999, pp. 2596-2604
Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer
Authors: Gandara, DR Edelman, MJ Lau, D
Citation: Dr. Gandara et al., Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer, SEMIN ONCOL, 26(3), 1999, pp. 3-7
Gemcitabine and carboplatin in combination: An update of phase I and phaseII studies in non-small cell lung cancer
Authors: Langer, CJ Gandara, DR Calvert, P Edelman, MJ Ozols, RF
Citation: Cj. Langer et al., Gemcitabine and carboplatin in combination: An update of phase I and phaseII studies in non-small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 12-18
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome
Authors: Edelman, MJ Gandara, DR Meyers, FJ Ishii, R O'Mahony, M Uhrich, M Lauder, I Houston, J Gietzen, DW
Citation: Mj. Edelman et al., Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome, CANCER, 86(4), 1999, pp. 684-688
Risultati: 1-9 |